Language

English

Publication Date

2-4-2025

Journal

The Journal of Infectious Diseases

DOI

10.1093/infdis/jiae504

PMID

39412209

Abstract

The development of SARS-CoV-2 next-generation vaccines with the potential for increased effectiveness, durability, breadth, and ability to decrease transmission are of public health importance. We highlight alternative routes of administration of next-generation SARS-CoV-2 vaccines such as mucosal and intradermal administration.

Keywords

Humans, Administration, Mucosal, COVID-19, COVID-19 Vaccines, Injections, Intradermal, SARS-CoV-2, COVID-19, SARS-CoV-2, mucosal immunity, next-generation, vaccines

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.